1. Introduction {#sec1-molecules-23-00582}
===============

The spiro\[pyrrolidine-2,3′-oxindole\] has been identified as the core structural skeleton in some unnatural compounds with diverse biological activities \[[@B1-molecules-23-00582],[@B2-molecules-23-00582],[@B3-molecules-23-00582],[@B4-molecules-23-00582],[@B5-molecules-23-00582],[@B6-molecules-23-00582]\]. As a subset of spiro\[pyrrolidine-2,3′-oxindole\], succinimide-fused spiro-\[pyrrolidine-2,3′-oxindole\] has been attracting more attention due to the recent discovery of some important biological activities such as anti-tumor \[[@B7-molecules-23-00582]\], Ape1 inhibitor \[[@B8-molecules-23-00582]\], and anti-fungal synergizer \[[@B9-molecules-23-00582]\] ([Figure 1](#molecules-23-00582-f001){ref-type="fig"}). As a consequence, much more attention has been paid to developing synthetic strategies toward the construction of this spirocyclic structure \[[@B2-molecules-23-00582],[@B7-molecules-23-00582],[@B9-molecules-23-00582],[@B10-molecules-23-00582],[@B11-molecules-23-00582],[@B12-molecules-23-00582],[@B13-molecules-23-00582],[@B14-molecules-23-00582],[@B15-molecules-23-00582],[@B16-molecules-23-00582]\]. Among these reported approaches, most studies have focused on 1,3-dipolar cycloaddition of azomethine ylides generated in situ via decarboxylative condensation of isatins with amino acids ([Scheme 1](#molecules-23-00582-sch001){ref-type="scheme"}a) \[[@B7-molecules-23-00582],[@B9-molecules-23-00582],[@B13-molecules-23-00582],[@B14-molecules-23-00582],[@B15-molecules-23-00582]\].

Although Zhao et al. developed a 1,3-dipolar cycloaddition of azomethine ylides generated in situ from isatins and arylmethylamines with maleimides ([Scheme 1](#molecules-23-00582-sch001){ref-type="scheme"}b) \[[@B16-molecules-23-00582]\], an urgent necessity is still in need to enrich the synthetic methodologies of spiro\[pyrrolidine-2,3′-oxindole\]. 1,3-dipolar cycloaddition of azomethine ylides derived from 3-aminooxindole with other alkenes such as nitroalkene derivatives \[[@B17-molecules-23-00582],[@B18-molecules-23-00582]\], α and β unsaturated imines \[[@B19-molecules-23-00582]\], and ketones \[[@B20-molecules-23-00582]\] were investigated. However, to our best knowledge, no azomethine ylides derived from aminoindolones were used in this kind of 1,3-dipolar cycloaddition. As well, azomethine ylides have been widely investigated in synthesizing spiro\[pyrrolidine-2,3′-oxindoles\] \[[@B17-molecules-23-00582],[@B18-molecules-23-00582],[@B19-molecules-23-00582],[@B20-molecules-23-00582],[@B21-molecules-23-00582]\]. Herein, we describe a facile and efficient strategy for accessing to succinimide-fused spiro\[pyrrolidine-2,3′-oxindoles\] by a one-pot three-component 1,3-dipolar cycloaddition reaction of azomethine ylides generated in situ from 3-amino oxindoles **1** and aldehydes **2** with maleimides **3** in the presence of triethylamine (TEA, [Scheme 1](#molecules-23-00582-sch001){ref-type="scheme"}c), which is a supplement to previous work.

2. Results and Discussion {#sec2-molecules-23-00582}
=========================

We commenced our studies with the three-component reaction of 3-amino-1-methylindolin-2-one hydrochloride **1a**, **2a**, and *N*-phenylmaleimide **3a** ([Scheme 2](#molecules-23-00582-sch002){ref-type="scheme"}) as model substrates for surveying the reaction parameters, and the results are summarized in [Table 1](#molecules-23-00582-t001){ref-type="table"}. Initially, the reaction was performed in the presence of 1 equivalent of weak inorganic base NaHCO~3~ and the desired product **4a** could be obtained in 60% yield with 74:26 diasteromeric excess (dr, [Table 1](#molecules-23-00582-t001){ref-type="table"}, entry 1). Other two weak inorganic bases, K~2~CO~3~ and KF/Al~2~O~3~, did not provide better results ([Table 1](#molecules-23-00582-t001){ref-type="table"}, entries 2 and 3). When the strong base NaOH was employed, only trace product was detected ([Table 1](#molecules-23-00582-t001){ref-type="table"}, entry 4). A further study showed that organic base TEA could afford **4a** in 68% yield and 83:17 dr ([Table 1](#molecules-23-00582-t001){ref-type="table"}, entry 6), and prolonging reaction time would benefit the reaction yield ([Table 1](#molecules-23-00582-t001){ref-type="table"}, entry 7). Subsequently, a series of solvents were also screened. As seen from [Table 1](#molecules-23-00582-t001){ref-type="table"}, with chlorinated alkane-type solvents, ether-type solvents, alcohol-type solvents, toluene or acetonitrile, the current strategy could afford the desired product **4a** in various yields and diastereoselectivities ([Table 1](#molecules-23-00582-t001){ref-type="table"}, entries 8--16). In terms of diastereoselectivity, CH~2~Cl~2~ was selected as the optimal reaction solvent ([Table 1](#molecules-23-00582-t001){ref-type="table"}, entry 8). When the reaction temperature was increased to reflux, up to 86% yield could be obtained without erosion in diastereoselectivity ([Table 1](#molecules-23-00582-t001){ref-type="table"}, entry 17). Scaling up reaction did not result in the loss of the reactivity and diastereoselectivity ([Table 1](#molecules-23-00582-t001){ref-type="table"}, entry 18).

Under optimum conditions, a variety of aldehyde substrates **2** were firstly investigated ([Scheme 3](#molecules-23-00582-sch003){ref-type="scheme"}). As shown in [Table 2](#molecules-23-00582-t002){ref-type="table"}, all tested aldehydes underwent the reaction smoothly to afford the corresponding products with good to excellent results. Both electron-withdrawing and electron-donating substituents on the aryl ring of R^2^ groups could be well tolerated ([Table 2](#molecules-23-00582-t002){ref-type="table"}, entries 2--19). It was shown that the positions of the substituents on the aryl ring of R^2^ groups seem to play a significant influence on the reaction results. The *ortho*- and *para*-substituents exhibit more beneficial impact on reaction yield and diastereoselectivity than *meta*-substituents ([Table 2](#molecules-23-00582-t002){ref-type="table"}, entries 2 and 4 vs. entry 3; entries 5 and 7 vs. entry 6; entries 9 and 11 vs. entry 10; entries 15 and 17 vs. entry 16; entry 18 vs. entry 19). The aldehyde adorned with 2-naphthyl group could be well performed, affording 93% yield and 94:6 dr ([Table 2](#molecules-23-00582-t002){ref-type="table"}, entry 20). Notably, as demonstrated by the examples with 2-furyl and 2-thienyl substituents, heteroaryl aldehydes **2u** and **2v** could be also well accommodated, giving 94:6 and 93:7 dr values, respectively ([Table 2](#molecules-23-00582-t002){ref-type="table"}, entries 21 and 22). In addition, aliphatic aldehydes could be tolerated albeit with moderate diastereoselectivities ([Table 2](#molecules-23-00582-t002){ref-type="table"}, entries 23 and 24).

To extend the utility of this procedure, we then screened a series of 3-amino oxindoles **1** and maleimides **3** ([Scheme 4](#molecules-23-00582-sch004){ref-type="scheme"}). As can be seen from [Table 3](#molecules-23-00582-t003){ref-type="table"}, the electronic property of the substituent R^1^ on aromatic ring of 3-amino oxindole seems to show significant influence on the diastereoselectivity of the reaction, and electron-donating group gave better dr value than electron-withdrawing group ([Table 3](#molecules-23-00582-t003){ref-type="table"}, entry 1 vs. entry 3, entry 2 vs. entry 4). Additionally, the *N*-protecting group R of 3-amino oxindole has also been found to have a major impact on the reaction result. When methyl-substituted **1a** was replaced with benzyl-substituted **1e**, the diastereoselectivity of the reaction was decreased from 88:12 to 83:17 ([Table 2](#molecules-23-00582-t002){ref-type="table"}, entry 1 vs. [Table 3](#molecules-23-00582-t003){ref-type="table"}, entry 6). Unprotected **1d** came to the worst results ([Table 3](#molecules-23-00582-t003){ref-type="table"}, entry 5). Next, to further validate the compatibility of this strategy, the scope of maleimides **3** was also explored. It was found that substrates **3** with either electron-withdrawing or electron-donating substituents R^3^ could be amenable to this reaction system ([Table 3](#molecules-23-00582-t003){ref-type="table"}, entries 8--13).

The relative configuration of 1,3-dipolar cycloaddition product **4k** was established by X-ray diffraction analysis ([Figure 2](#molecules-23-00582-f002){ref-type="fig"}) \[[@B22-molecules-23-00582]\], the relevant data shown in [Supplementary Materials](#app1-molecules-23-00582){ref-type="app"} and the relative configurations of other succinimide-fused spiro\[pyrrolidine-2,3′-oxindole\] products were assigned by analogy.

3. Materials and Methods {#sec3-molecules-23-00582}
========================

3.1. Experimental {#sec3dot1-molecules-23-00582}
-----------------

All reactions were carried out in reaction tubes with magnetic stirring and no special precautions were taken to exclude air from the reaction vessels. TLC was performed on pre-coated silica gel plates (Qingdao Marine Chemistry Company, Qingdao, China). Column chromatography was carried out with silica gel (200--300 mesh, Qingdao Marine Chemistry Company, Qingdao, China) eluting with ethyl acetate and petroleum ether. NMR spectra were recorded with a Bruker Avance II 400 NMR spectrometer (Bruker Biospin, Fällanden, Switzerland). Chemical shifts are reported in parts per million (ppm) downfield from TMS (Aladdin, Shanghai, China) with the solvent resonance as the internal standard. Coupling constants (*J*) are reported in Hz and refer to apparent peak multiplications. High Resolution Mass Spectrometer (HRMS) was recorded on a Bruker micrOTOF-Q II mass spectrometer (Bruker Daltonics Inc., Billerica, Massachusetts, MA, USA). X-ray diffraction analysis was recorded with a Bruker Apex-II spectrometer (Bruker AXS, Karlsruhe, Germany).

3.2. General Procedure forthe Preparation of Succinimide-Fused Spiro\[Pyrrolidine-2,3′-Oxindoles\] ***4*** and ***5*** {#sec3dot2-molecules-23-00582}
----------------------------------------------------------------------------------------------------------------------

3-Amino oxindoles **1** (0.2 mmol), aldehydes **2** (0.2 mmol) and TEA (0.2 mmol) were put into an ordinary test tube equipped with a magnetic stirring bar and then sealed in the air. Then, CH~2~Cl~2~ (1 mL) was added. After being stirred at room temperature for 30 min, maleimides **3** (0.22 mmol) and CH~2~Cl~2~ (1 mL) were added and the resulting mixture was stirred at reflux for 24 h. The crude reaction mixture was directly purified by flash column chromatography on silica gel (petroleum ether/ethyl acetate = 7:1--3:1) to give the correspondingsuccinimide-fused spiro\[pyrrolidine-2,3′-oxindole\] products **4** or **5**. All the products were confirmed by ^1^H-NMR, ^13^C-NMR and HRMS spectroscopic analysis. The diastereomeric ratio was determined by crude NMR analysis.

*1-Methyl-3′,5′-diphenyl-2′,3′,3a′,6a′-tetrahydro-4′H-spiro\[indoline-3,1′-pyrrolo\[3,4-c\]pyrrole\]-2,4′,6′(5′H)-trione* (**4a**). White solid, 71.9 mg, 85% yield. 88:12 dr. ^1^H-NMR (400 MHz, CDCl~3~): δ 7.56 (d, *J* = 7.2 Hz, 2H), 7.48--7.43 (m, 2H), 7.41--7.36 (m, 4H), 7.36--7.31 (m, 2H), 7.24 (d, *J* = 7.4 Hz, 2H), 7.14 (t, *J* = 7.6 Hz, 1H), 6.90 (d, *J* = 7.8 Hz, 1H), 5.83 (d, *J* = 8.8 Hz, 1H), 4.03 (t, *J* = 8.4 Hz, 1H), 3.55 (d, *J* = 7.9 Hz, 1H), 3.25 (s, 3H); ^13^C-NMR (100 MHz, CDCl~3~): δ 178.8, 174.1, 173.5, 143.7, 138.0, 130.2, 129.1, 128.5, 128.4, 128.3, 127.3, 127.0, 126.2, 125.4, 122.8, 108.4, 68.0, 60.8, 50.9, 49.5, 26.2; HRMS (ESI): *m*/*z* calcd for C~26~H~21~NaN~3~O~3~^+^ \[M + Na\]^+^ 446.1481, found 446.1493.

*3′-(4-Fluorophenyl)-1-methyl-5′-phenyl-2′,3′,3a′,6a′-tetrahydro-4′H-spiro\[indoline-3,1′-pyrrolo\[3,4-c\]pyrrole\]-2,4′,6′(5′H)-trione* (**4b**). White solid, 70.6 mg, 80% yield. 81:19 dr. ^1^H-NMR (400 MHz, CDCl~3~): δ 7.51 (dd, *J* = 7.7, 5.8 Hz, 2H), 7.45 (t, *J* = 7.6 Hz, 2H), 7.38 (dd, *J* = 13.7, 7.0 Hz, 2H), 7.32 (d, *J* = 7.5 Hz, 1H), 7.22 (d, *J* = 7.6 Hz, 2H), 7.12 (t, *J* = 7.5 Hz, 1H), 7.06 (t, *J* = 8.4 Hz, 2H), 6.89 (d, *J* = 7.8 Hz, 1H), 5.80 (d, *J* = 8.7 Hz, 1H), 3.97 (t, *J* = 8.3 Hz, 1H), 3.53 (d, *J* = 7.9 Hz, 1H), 3.23 (s, 3H); ^13^C-NMR (100 MHz, CDCl~3~): δ 178.7, 174.2, 173.5, 143.7, 130.3, 129.2, 128.9, 128.8, 128.6, 126.9, 126.1, 125.3, 122.8, 115.4, 115.2, 108.5, 67.9, 60.0, 50.8, 49.4, 26.2; HRMS (ESI): *m*/*z* calcd for C~26~H~20~FN~3~NaO~3~^+^ \[M + Na\]^+^ 442.1567, found 442.1579.

*3′-(3-Fluorophenyl)-1-methyl-5′-phenyl-2′,3′,3a′,6a′-tetrahydro-4′H-spiro\[indoline-3,1′-pyrrolo\[3,4-c\]pyrrole\]-2,4′,6′(5′H)-trione* (**4c**). White solid, 61.8 mg, 70% yield. 62:38 dr. ^1^H-NMR (400 MHz, CDCl~3~): δ 7.45 (t, *J* = 7.6 Hz, 2H), 7.39 (dd, *J* = 15.4, 7.8 Hz, 3H), 7.32 (t, *J* = 9.0 Hz, 3H), 7.22 (d, *J* = 7.6 Hz, 2H), 7.13 (t, *J* = 7.5 Hz, 1H), 7.00 (dd, *J* = 10.4, 5.5 Hz, 1H), 6.89 (d, *J* = 7.8 Hz, 1H), 5.81 (d, *J* = 8.8 Hz, 1H), 4.01 (t, *J* = 8.4 Hz, 1H), 3.54 (d, *J* = 7.9 Hz, 1H), 3.24 (s, 3H); ^13^C-NMR (100 MHz, CDCl~3~): δ 178.7, 174.0, 173.4, 143.7, 130.3, 129.9, 129.2, 128.7, 127.0, 126.2, 123.2, 122.9, 115.1, 114.1, 113.9, 108.5, 67.9, 60.1, 50.8, 49.4, 26.2; HRMS (ESI): *m*/*z* calcd for C~26~H~20~FN~3~NaO~3~^+^\[M + Na\]^+^ 442.1567, found 442.1576.

*3′-(2-Fluorophenyl)-1-methyl-5′-phenyl-2′,3′,3a′,6a′-tetrahydro-4′H-spiro\[indoline-3,1′-pyrrolo\[3,4-c\]pyrrole\]-2,4′,6′(5′H)-trione* (**4d**). White solid, 79.4 mg, 90% yield. 92:8 dr. ^1^H-NMR (400 MHz, CDCl~3~): δ 7.57 (t, *J* = 7.1 Hz, 1H), 7.43--7.38 (m, 4H), 7.30 (d, *J* = 5.9 Hz, 1H), 7.20 (d, *J* = 7.6 Hz, 2H), 7.16--7.08 (m, 4H), 6.89 (d, *J* = 7.8 Hz, 1H), 6.01 (d, *J* = 8.4 Hz, 1H), 4.13 (t, *J* = 8.2 Hz, 1H), 3.61 (d, *J* = 8.0 Hz, 1H), 3.24 (s, 3H); ^13^C-NMR (100 MHz, CDCl~3~): δ 178.6, 174.0, 173.5, 143.8, 130.3, 129.5, 128.6, 127.0, 126.9, 126.7, 126.2, 122.9, 115.2, 115.0, 108.5, 67.8, 54.7, 51.1, 48.0, 26.2; HRMS (ESI): *m*/*z* calcd for C~26~H~20~FN~3~NaO~3~^+^ \[M + Na\]^+^ 442.1567, found 442.1573.

*3′-(4-Chlorophenyl)-1-methyl-5′-phenyl-2′,3′,3a′,6a′-tetrahydro-4′H-spiro\[indoline-3,1′-pyrrolo\[3,4-c\]pyrrole\]-2,4′,6′(5′H)-trione* (**4e**). White solid, 72.2 mg, 79% yield. 81:19 dr. ^1^H-NMR (400 MHz, CDCl~3~): δ 7.47 (t, *J* = 8.4 Hz, 5H), 7.38--7.30 (m, 4H), 7.24 (d, *J* = 7.5 Hz, 2H), 7.14 (t, *J* = 7.5 Hz, 1H), 6.90 (d, *J* = 7.8 Hz, 1H), 5.80 (d, *J* = 8.7 Hz, 1H), 4.00 (t, *J* = 8.3 Hz, 1H), 3.56 (d, *J* = 7.9 Hz, 1H), 3.25 (s, 3H); ^13^C-NMR (100 MHz, CDCl~3~): δ 178.7, 174.0, 173.4, 143.7, 136.5, 133.9, 131.7, 130.3, 129.2, 128.7, 128.6, 126.9, 126.1, 125.3, 122.9, 108.5, 67.9, 60.1, 50.8, 49.4, 26.2; HRMS (ESI): *m*/*z* calcd for C~26~H~20~ClN~3~NaO~3~^+^ \[M + Na\]^+^ 480.1091, found 480.1090.

*3′-(3-Chlorophenyl)-1-methyl-5′-phenyl-2′,3′,3a′,6a′-tetrahydro-4′H-spiro\[indoline-3,1′-pyrrolo\[3,4-c\]pyrrole\]-2,4′,6′(5′H)-trione* (**4f**). White solid, 64.9 mg, 71% yield. 76:24 dr. ^1^H-NMR (400 MHz, CDCl~3~): δ 7.58 (s, 1H), 7.47 (t, *J* = 7.5 Hz, 2H), 7.41 (t, *J* = 7.5 Hz, 3H), 7.34 (dd, *J* = 14.0, 7.1 Hz, 3H), 7.24 (d, *J* = 7.6 Hz, 2H), 7.14 (t, *J* = 7.5 Hz, 1H), 6.90 (d, *J* = 7.8 Hz, 1H), 5.80 (d, *J* = 8.8 Hz, 1H), 4.03 (t, *J* = 8.4 Hz, 1H), 3.54 (d, *J* = 7.9 Hz, 1H), 3.25 (s, 3H); ^13^C-NMR (100 MHz, CDCl~3~): δ 178.6, 174.0, 173.3, 143.7, 140.3, 134.4, 130.3, 129.7, 129.2, 128.7, 128.4, 127.1, 126.7, 126.2, 125.9, 122.9, 108.4, 68.0, 60.1, 50.7, 49.4, 26.2; HRMS (ESI): *m*/*z* calcd for C~26~H~20~ClN~3~NaO~3~^+^ \[M + Na\]^+^ 480.1091, found 480.1109.

*3′-(2-Chlorophenyl)-1-methyl-5′-phenyl-2′,3′,3a′,6a′-tetrahydro-4′H-spiro\[indoline-3,1′-pyrrolo\[3,4-c\]pyrrole\]-2,4′,6′(5′H)-trione* (**4g**). White solid, 75.9 mg, 83% yield. 81:19 dr. ^1^H-NMR (400 MHz, CDCl~3~): δ 7.69 (dd, *J* = 5.6, 3.8 Hz, 1H), 7.48--7.44 (m, 2H), 7.42 (d, *J* = 7.6 Hz, 3H), 7.40--7.34 (m, 2H), 7.33 (d, *J* = 7.6 Hz, 1H), 7.20 (d, *J* = 7.5 Hz, 2H), 7.14 (t, *J* = 7.5 Hz, 1H), 6.91 (d, *J* = 7.8 Hz, 1H), 6.11 (d, *J* = 8.4 Hz, 1H), 4.31 (t, *J* = 8.1 Hz, 1H), 3.62 (d, *J* = 8.0 Hz, 1H), 3.26 (s, 3H); ^13^C-NMR (100 MHz, CDCl~3~): δ 178.6, 173.8, 173.5, 143.8, 136.0, 134.0, 130.3, 129.4, 129.1, 129.0, 128.5, 127.0, 126.8, 126.7, 126.2, 122.9, 108.5, 67.6, 57.6, 51.0, 47.0, 26.2; HRMS (ESI): *m*/*z* calcd for C~26~H~20~ClN~3~NaO~3~^+^ \[M + Na\]^+^ 480.1091, found 480.1116.

*3′-(3,4-Dichlorophenyl)-1-methyl-5′-phenyl-2′,3′,3a′,6a′-tetrahydro-4′H-spiro\[indoline-3,1′-pyrrolo\[3,4-c\]pyrrole\]-2,4′,6′(5′H)-trione* (**4h**). White solid, 83.5 mg, 85% yield. 86:14 dr. ^1^H-NMR (400 MHz, CDCl~3~): δ 7.64 (s, 1H), 7.46 (dd, *J* = 15.9, 7.9 Hz, 3H), 7.42--7.35 (m, 3H), 7.35--7.29 (m, 1H), 7.22 (d, *J* = 7.6 Hz, 2H), 7.13 (t, *J* = 7.5 Hz, 1H), 6.89 (d, *J* = 7.8 Hz, 1H), 5.76 (dd, *J* = 8.6, 3.2 Hz, 1H), 3.99 (t, *J* = 8.3 Hz, 1H), 3.53 (d, *J* = 7.9 Hz, 1H), 3.23 (s, 3H); ^13^C-NMR (100 MHz, CDCl~3~): δ 178.5, 173.9, 173.2, 143.7, 138.5, 132.1, 130.4, 129.3, 128.9, 128.8, 127.0, 126.2, 124.9, 122.9, 108.5, 67.9, 59.6, 50.7, 49.3, 26.2; HRMS (ESI): *m*/*z* calcd for C~26~H~20~Cl~2~N~3~O~3~^+^ \[M + H\]^+^ 492.0882, found 492.0905.

*3′-(4-Bromophenyl)-1-methyl-5′-phenyl-2′,3′,3a′,6a′-tetrahydro-4′H-spiro\[indoline-3,1′-pyrrolo\[3,4-c\]pyrrole\]-2,4′,6′(5′H)-trione* (**4i**). White solid, 81.2 mg, 81% yield. \>95:5 dr. ^1^H-NMR (400 MHz, CDCl~3~): δ 7.47 (dd, *J* = 16.4, 8.1 Hz, 4H), 7.39 (dd, *J* = 12.5, 5.4 Hz, 4H), 7.31 (d, *J* = 7.3 Hz, 1H), 7.22 (d, *J* = 7.6 Hz, 2H), 7.12 (t, *J* = 7.5 Hz, 1H), 6.89 (d, *J* = 7.8 Hz, 1H), 5.77 (d, *J* = 7.4 Hz, 1H), 3.98 (t, *J* = 8.3 Hz, 1H), 3.55 (d, *J* = 7.9 Hz, 1H), 3.23 (s, 3H); ^13^C-NMR (100 MHz, CDCl~3~): δ 178.7, 173.9, 173.3, 143.7, 137.0, 131.5, 130.3, 129.2, 129.0, 128.6, 126.9, 126.1, 125.3, 122.9, 122.1, 108.4, 67.9, 60.2, 50.9, 49.3, 26.2; HRMS (ESI): *m*/*z* calcd for C~26~H~20~BrN~3~NaO~3~^+^ \[M + Na\]^+^ 524.0586, found 524.0567.

*3′-(3-Bromophenyl)-1-methyl-5′-phenyl-2′,3′,3a′,6a′-tetrahydro-4′H-spiro\[indoline-3,1′-pyrrolo\[3,4-c\]pyrrole\]-2,4′,6′(5′H)-trione* (**4j**).White solid, 65.1 mg, 65% yield. 67:33 dr. ^1^H-NMR (400 MHz, CDCl~3~): δ 7.72 (s, 1H), 7.46 (t, *J* = 7.7 Hz, 4H), 7.40 (t, *J* = 7.1 Hz, 2H), 7.34 (d, *J* = 7.4 Hz, 1H), 7.24 (dd, *J* = 7.5, 4.7 Hz, 3H), 7.13 (t, *J* = 7.5 Hz, 1H), 6.89 (d, *J* = 7.8 Hz, 1H), 5.78 (d, *J* = 8.9 Hz, 1H), 4.02 (t, *J* = 8.4 Hz, 1H), 3.53 (d, *J* = 7.9 Hz, 1H), 3.24 (s, 3H); ^13^C-NMR (100 MHz, CDCl~3~): δ 178.6, 173.9, 173.2, 143.7, 140.6, 131.4, 130.3, 130.0, 129.9, 129.2, 128.6, 127.1, 126.4, 126.2, 125.0, 122.9, 108.4, 68.0, 60.1, 50.7, 49.4, 26.2; HRMS (ESI): *m*/*z* calcd for C~26~H~20~BrN~3~NaO~3~^+^ \[M + Na\]^+^ 524.0586, found 524.0570.

*3′-(2-Bromophenyl)-1-methyl-5′-phenyl-2′,3′,3a′,6a′-tetrahydro-4′H-spiro\[indoline-3,1′-pyrrolo\[3,4-c\]pyrrole\]-2,4′,6′(5′H)-trione* (**4k**). White solid, 90.2 mg, 90% yield. 93:7 dr. ^1^H-NMR (400 MHz, CDCl~3~): δ 7.70--7.65 (m, 1H), 7.62 (d, *J* = 7.9 Hz, 1H), 7.41 (d, *J* = 7.7 Hz, 3H), 7.39--7.29 (m, 3H), 7.19 (d, *J* = 7.5 Hz, 3H), 7.13 (t, *J* = 7.5 Hz, 1H), 6.90 (d, *J* = 7.8 Hz, 1H), 6.07 (d, *J* = 8.3 Hz, 1H), 4.34 (t, *J* = 8.2 Hz, 1H), 3.60 (d, *J* = 8.0 Hz, 1H), 3.25 (s, 3H); ^13^C-NMR (100 MHz, CDCl~3~): δ 178.6, 173.8, 173.5, 143.8, 137.6, 132.7, 130.3, 129.4, 129.1, 128.5, 127.4, 127.2, 126.8, 126.1, 124.3, 122.9, 108.5, 67.7 , 59.9, 50.8, 46.9, 26.2; HRMS (ESI): *m*/*z* calcd for C~26~H~20~BrN~3~NaO~3~^+^ \[M + Na\]^+^ 524.0586, found 524.0561.

*1-Methyl-3′-(4-nitrophenyl)-5′-phenyl-2′,3′,3a′,6a′-tetrahydro-4′H-spiro\[indoline-3,1′-pyrrolo\[3,4-c\]pyrrole\]-2,4′,6′(5′H)-trione* (**4l**). White solid, 79.6 mg, 85% yield. \>95:5 dr. ^1^H-NMR (400 MHz, CDCl~3~): δ 8.24 (d, *J* = 8.6 Hz, 2H), 7.72 (d, *J* = 8.6 Hz, 2H), 7.47 (dd, *J* = 12.9, 5.2 Hz, 2H), 7.41 (dd, *J* = 7.6, 2.2 Hz, 2H), 7.32 (d, *J* = 7.3 Hz, 1H), 7.23 (d, *J* = 7.6 Hz, 2H), 7.16 (t, *J* = 7.5 Hz, 1H), 6.92 (d, *J* = 7.8 Hz, 1H), 5.94 (d, *J* = 8.5 Hz, 1H), 4.06 (t, *J* = 8.3 Hz, 1H), 3.62 (d, *J* = 8.0 Hz, 1H), 3.26 (s, 3H); ^13^C-NMR (100 MHz, CDCl~3~): δ 178.5, 173.8, 173.1, 147.7, 145.6, 143.7, 131.4, 130.5, 129.3, 128.9, 128.1, 126.8, 126.1, 125.0, 123.6, 123.5, 123.1, 108.7, 68.0, 60.0, 50.7, 49.5, 26.3; HRMS (ESI): *m*/*z* calcd for C~26~H~20~N~4~NaO~5~^+^ \[M + Na\]^+^ 491.1331, found 491.1331.

*1-Methyl-3′-(3-nitrophenyl)-5′-phenyl-2′,3′,3a′,6a′-tetrahydro-4′H-spiro\[indoline-3,1′-pyrrolo\[3,4-c\]pyrrole\]-2,4′,6′(5′H)-trione* (**4m**). White solid; 77.7 mg, 83% yield; \>95:5 dr; ^1^H-NMR (400 MHz, CDCl~3~): δ 8.43 (s, 1H), 8.17 (d, *J* = 7.9 Hz, 1H), 7.84 (d, *J* = 7.6 Hz, 1H), 7.55 (t, *J* = 7.9 Hz, 1H), 7.45 (d, *J* = 7.8 Hz, 2H), 7.40 (dd, *J* = 7.3, 3.6 Hz, 2H), 7.33 (d, *J* = 7.3 Hz, 1H), 7.23 (d, *J* = 7.7 Hz, 2H), 7.15 (t, *J* = 7.5 Hz, 1H), 6.90 (d, *J* = 7.7 Hz, 1H), 5.93 (d, *J* = 8.5 Hz, 1H), 4.04 (t, *J* = 8.2 Hz, 1H), 3.60 (d, *J* = 7.9 Hz, 1H), 3.25 (s, 3H); ^13^C-NMR (100 MHz, CDCl~3~): δ 178.6, 174.0, 173.2, 148.4 , 143.7, 140.4, 133.9, 130.5, 129.4, 129.3, 129.2, 128.9, 126.9, 126.4, 126.3, 123.3, 123.1, 122.0, 108.6, 67.9, 59.9, 50.7, 49.4, 26.2; HRMS (ESI): *m*/*z* calcd for C~26~H~20~N~4~NaO~5~^+^ \[M + Na\]^+^ 491.1331, found 491.1332.

*1-Methyl-3′-(2-nitrophenyl)-5′-phenyl-2′,3′,3a′,6a′-tetrahydro-4′H-spiro\[indoline-3,1′-pyrrolo\[3,4-c\]pyrrole\]-2,4′,6′(5′H)-trione* (**4n**). White solid; 80.5 mg, 86% yield; 94:6 dr; ^1^H-NMR (400 MHz, CDCl~3~): δ 8.13 (d, *J* = 8.1 Hz, 1H), 8.06 (d, *J* = 7.8 Hz, 1H), 7.62 (t, *J* = 7.6 Hz, 1H), 7.44--7.38 (m, 3H), 7.38--7.32 (m, 3H), 7.17 (d, *J* = 7.6 Hz, 2H), 7.13 (t, *J* = 7.5 Hz, 1H), 6.89 (d, *J* = 7.8 Hz, 1H), 6.23 (dd, *J* = 8.2, 2.8 Hz, 1H), 4.51 (t, *J* = 8.2 Hz, 1H), 3.60 (d, *J* = 8.1 Hz, 1H), 3.22 (s, 3H); ^13^C-NMR (100 MHz, CDCl~3~): δ 178.5, 174.2, 173.4, 148.7, 143.8, 134.5, 133.4, 130.4, 129.2, 128.8, 128.7, 128.1, 126.7, 126.1, 125.3, 122.8, 108.6, 67.7, 56.9, 50.7, 48.5, 26.2; HRMS (ESI): *m*/*z* calcd for C~26~H~20~N~4~NaO~5~^+^ \[M + Na\]^+^ 491.1331, found 491.1350.

*1-Methyl-5′-phenyl-3′-(p-tolyl)-2′,3′,3a′,6a′-tetrahydro-4′H-spiro\[indoline-3,1′-pyrrolo\[3,4-c\]pyrrole\]-2,4′,6′(5′H)-trione* (**4o**). White solid; 68.2 mg, 78% yield; 82:18 dr; ^1^H-NMR (400 MHz, CDCl~3~): δ 7.43 (dd, *J* = 14.0, 6.1 Hz, 3H), 7.38 (d, *J* = 3.3 Hz, 1H), 7.35 (d, *J* = 3.5 Hz, 4H), 7.23 (d, *J* = 7.7 Hz, 2H), 7.12 (dd, *J* = 8.7, 5.2 Hz, 2H), 6.88 (d, *J* = 8.0 Hz, 1H), 5.76 (d, *J* = 8.9 Hz, 1H), 4.00 (t, *J* = 8.4 Hz, 1H), 3.50 (d, *J* = 7.9 Hz, 1H), 3.23 (s, 3H), 2.36 (s, 3H); ^13^C-NMR (100 MHz, CDCl~3~): δ 178.8, 174.2, 173.5, 143.8, 138.0, 137.9, 130.2, 129.1, 128.5, 128.3, 128.0, 127.1, 126.2, 124.5, 122.8, 108.4, 68.1 , 60.7, 50.9, 49.5, 26.2, 21.6; HRMS (ESI): *m*/*z* calcd for C~27~H~23~N~3~NaO~3~^+^ \[M + Na\]^+^ 460.1637, found 460.1658.

*1-Methyl-5′-phenyl-3′-(m-tolyl)-2′,3′,3a′,6a′-tetrahydro-4′H-spiro\[indoline-3,1′-pyrrolo\[3,4-c\]pyrrole\]-2,4′,6′(5′H)-trione* (**4p**). White solid; 62.1 mg, 71% yield; 75:25 dr; ^1^H-NMR (400 MHz, CDCl~3~): δ 7.46--7.40 (m, 4H), 7.37 (d, *J* = 7.4 Hz, 2H), 7.34 (d, *J* = 7.3 Hz, 1H), 7.24 (d, *J* = 7.5 Hz, 2H), 7.18 (d, *J* = 7.8 Hz, 2H), 7.12 (t, *J* = 7.5 Hz, 1H), 6.88 (d, *J* = 7.7 Hz, 1H), 5.78 (d, *J* = 8.7 Hz, 1H), 3.98 (t, *J* = 8.4 Hz, 1H), 3.52 (d, *J* = 7.9 Hz, 1H), 3.23 (s, 3H), 2.35 (s, 3H); ^13^C-NMR (100 MHz, CDCl~3~): δ 178.8, 174.2, 173.6, 143.7, 137.9, 134.9, 130.2, 129.2, 129.1, 128.5, 127.2, 127.0, 126.7, 126.2, 125.5, 122.8, 108.4, 67.9, 60.6, 51.0, 49.5, 26.2, 21.3; HRMS (ESI): *m*/*z* calcd for C~27~H~24~N~3~O~3~^+^ \[M + H\]^+^ 438.1818, found 438.1825.

*1-Methyl-5′-phenyl-3′-(o-tolyl)-2′,3′,3a′,6a′-tetrahydro-4′H-spiro\[indoline-3,1′-pyrrolo\[3,4-c\]pyrrole\]-2,4′,6′(5′H)-trione* (**4q**). White solid; 69.9 mg, 80% yield; 77:23 dr; ^1^H-NMR (400 MHz, CDCl~3~): δ 7.75--7.68 (m, 1H), 7.40 (t, *J* = 7.7 Hz, 4H), 7.36--7.30 (m, 1H), 7.21 (d, *J* = 7.8 Hz, 3H), 7.13 (t, *J* = 8.4 Hz, 3H), 6.90 (d, *J* = 7.7 Hz, 1H), 5.94 (d, *J* = 9.0 Hz, 1H), 4.13 (t, *J* = 8.4 Hz, 1H), 3.53 (d, *J* = 7.9 Hz, 1H), 3.25 (s, 3H), 2.54 (s, 3H); ^13^C-NMR (100 MHz, CDCl~3~): δ 178.8, 173.9, 173.5, 143.8, 136.6, 130.3, 130.2, 129.1, 128.5, 127.8, 127.3, 126.2, 125.8, 125.1, 122.8, 108.4, 67.8, 57.1, 50.9, 47.2, 26.2, 19.5; HRMS (ESI): *m*/*z* calcd for C~27~H~23~N~3~NaO~3~^+^ \[M + Na\]^+^ 460.1637, found 460.1646.

*3′-(4-Methoxyphenyl)-1-methyl-5′-phenyl-2′,3′,3a′,6a′-tetrahydro-4′H-spiro\[indoline-3,1′-pyrrolo\[3,4-c\]pyrrole\]-2,4′,6′(5′H)-trione* (**4r**). White solid; 76.1 mg, 84% yield; 83:17 dr; ^1^H-NMR (400 MHz, CDCl~3~): δ 7.46 (t, *J* = 7.7 Hz, 4H), 7.41--7.35 (m, 3H), 7.28--7.24 (m, 2H), 7.13 (t, *J* = 7.6 Hz, 1H), 6.94--6.88 (m, 3H), 5.78 (d, *J* = 8.8 Hz, 1H), 3.99 (t, *J* = 8.5 Hz, 1H), 3.82 (s, 3H), 3.53 (d, *J* = 7.9 Hz, 1H), 3.25 (s, 3H); ^13^C-NMR (100MHz, CDCl~3~): δ 178.8, 174.2, 173.5, 143.8, 138.0, 137.9, 129.1, 128.5, 128.3, 128.0, 127.1, 126.2, 124.5, 122.8, 108.4, 68.1, 60.7, 50.9, 49.5, 26.2, 21.6; HRMS (ESI): *m*/*z* calcd for C~27~H~23~N~3~NaO~4~^+^ \[M + Na\]^+^ 476.1586, found 476.1597.

*3′-(3-Methoxyphenyl)-1-methyl-5′-phenyl-2′,3′,3a′,6a′-tetrahydro-4′H-spiro\[indoline-3,1′-pyrrolo\[3,4-c\]pyrrole\]-2,4′,6′(5′H)-trione* (**4s**). White solid; 68.9 mg, 76% yield; 80:20 dr; ^1^H-NMR (400 MHz, CDCl~3~): δ 7.48--7.42 (m, 2H), 7.41--7.30 (m, 4H), 7.27--7.22 (m, 2H), 7.14 (dd, *J* = 12.9, 5.2 Hz, 3H), 6.89 (d, *J* = 7.9 Hz, 1H), 6.86 (dd, *J* = 7.9, 2.2 Hz, 1H), 5.79 (d, *J* = 8.9 Hz, 1H), 4.02 (t, *J* = 8.4 Hz, 1H), 3.81 (s, 3H), 3.53 (d, *J* = 7.9 Hz, 1H), 3.25 (s, 3H); ^13^C-NMR (100 MHz, CDCl~3~): δ 178.7, 174.0, 173.5, 143.7, 139.8, 130.2, 129.4, 129.1, 128.5, 127.1, 126.7, 126.2, 125.3, 122.8, 119.8, 108.4, 68.0, 60.6, 55.2, 50.9, 49.4, 26.2; HRMS (ESI): *m*/*z* calcd for C~27~H~23~N~3~NaO~4~^+^ \[M + Na\]^+^ 476.1586, found 476.1605.

*1-Methyl-3′-(naphthalen-1-yl)-5′-phenyl-2′,3′,3a′,6a′-tetrahydro-4′H-spiro\[indoline-3,1′-pyrrolo\[3,4-c\]pyrrole\]-2,4′,6′(5′H)-trione* (**4t**). White solid; 88.0 mg, 93% yield; 94:6 dr; ^1^H-NMR (400 MHz, CDCl~3~): δ 8.26 (d, *J* = 8.4 Hz, 1H), 7.90 (d, *J* = 8.4 Hz, 2H), 7.83 (d, *J* = 8.1 Hz, 1H), 7.64 (t, *J* = 7.5 Hz, 1H), 7.54 (t, *J* = 7.5 Hz, 1H), 7.48 (d, *J* = 7.8 Hz, 1H), 7.41 (dd, *J* = 14.6, 7.3 Hz, 5H), 7.18--7.12 (m, 3H), 6.93 (d, *J* = 7.9 Hz, 1H), 6.57 (d, *J* = 8.5 Hz, 1H), 4.32 (t, *J* = 8.2 Hz, 1H), 3.64 (d, *J* = 7.8 Hz, 1H), 3.28 (s, 3H); ^13^C-NMR (100 MHz, CDCl~3~): δ 178.7, 173.6, 173.5, 143.8,130.3, 129.1, 129.0, 128.6, 128.5, 127.1, 126.5, 126.2, 125.8, 125.2, 122.9, 108.5, 67.7, 56.5, 51.1, 48.4, 26.2; HRMS (ESI): *m*/*z* calcd for C~30~H~23~N~3~NaO~3~^+^ \[M + Na\]^+^ 496.1637, found 496.1651.

*3′-(Furan-2-yl)-1-methyl-5′-phenyl-2′,3′,3a′,6a′-tetrahydro-4′H-spiro\[indoline-3,1′-pyrrolo\[3,4-c\]pyrrole\]-2,4′,6′(5′H)-trione* (**4u**). White solid; 57.8 mg, 70% yield; 94:6 dr; ^1^H-NMR (400 MHz, CDCl~3~): δ 7.48 (d, *J* = 8.0 Hz, 3H), 7.39 (dd, *J* = 16.4, 7.7 Hz, 3H), 7.32 (d, *J* = 7.5 Hz, 2H), 7.10 (t, *J* = 7.6 Hz, 1H), 6.88 (d, *J* = 7.8 Hz, 1H), 6.43 (d, *J* = 3.1 Hz, 1H), 6.40--6.36 (m, 1H), 5.78 (d, *J* = 8.8 Hz, 1H), 4.02 (t, *J* = 8.4 Hz, 1H), 3.51 (d, *J* = 8.0 Hz, 1H), 3.21 (s, 3H); ^13^C-NMR (100 MHz, CDCl~3~): δ 178.3, 174.4, 173.5, 151.2, 143.8, 142.7, 131.9, 130.3, 129.2, 128.7, 126.9, 126.3, 124.8, 122.8, 110.4, 108.4, 108.1, 67.9, 55.8, 50.7, 48.6, 26.2; HRMS (ESI): *m*/*z* calcd for C~24~H~19~N~3~NaO~4~^+^ \[M + Na\]^+^ 436.1273, found 436.1290.

*1-Methyl-5′-phenyl-3′-(thiophen-2-yl)-2′,3′,3a′,6a′-tetrahydro-4′H-spiro\[indoline-3,1′-pyrrolo\[3,4-c\]pyrrole\]-2,4′,6′(5′H)-trione* (**4v**). White solid; 67.8 mg, 79% yield; 93:7 dr; ^1^H-NMR (400 MHz, CDCl~3~): δ 7.47 (t, *J* = 7.6 Hz, 2H), 7.39 (dd, *J* = 7.5, 5.4 Hz, 2H), 7.34 (d, *J* = 7.6 Hz, 1H), 7.29 (s, 1H), 7.28 (d, *J* = 2.1 Hz, 2H), 7.22 (d, *J* = 3.2 Hz, 1H), 7.13 (t, *J* = 7.5 Hz, 1H), 7.08-7.04 (m, 1H), 6.89 (d, *J* = 7.7 Hz, 1H), 6.11 (d, *J* = 9.1 Hz, 1H), 4.02 (t, *J* = 8.5 Hz, 1H), 3.49 (d, *J* = 1.7 Hz, 1H), 3.24 (s, 3H); ^13^C-NMR (100 MHz, CDCl~3~): δ 178.5, 173.8, 173.4, 143.7, 142.7, 131.8, 130.3, 129.2, 128.6, 127.3, 127.2, 126.7, 126.4, 125.5, 125.0, 124.8, 122.8, 108.4, 67.8, 57.1, 50.5, 49.3, 26.2; HRMS (ESI): *m*/*z* calcd for C~24~H~19~N~3~NaO~3~S^+^ \[M + Na\]^+^ 452.1045, found 452.1066.

*3′-Benzyl-1-methyl-5′-phenyl-2′,3′,3a′,6a′-tetrahydro-4′H-spiro\[indoline-3,1′-pyrrolo\[3,4-c\]pyrrole\]-2,4′,6′(5′H)-trione* (**4w**). White solid; 66.5 mg, 76% yield; 77:23 dr; ^1^H-NMR (400 MHz, CDCl~3~): δ 7.56 (t, *J* = 7.6 Hz, 2H), 7.46 (dd, *J* = 12.7, 7.4 Hz, 4H), 7.31 (t, *J* = 7.2 Hz, 5H), 7.23 (dd, *J* = 13.3, 6.6 Hz, 2H), 6.82 (d, *J* = 7.7 Hz, 1H), 4.87--4.78 (m, 1H), 3.77 (t, *J* = 7.8 Hz, 1H), 3.57 (d, *J* = 8.0 Hz, 1H), 3.29--3.23 (m, 1H), 3.15 (s, 3H), 2.80--2.71 (m, 1H); ^13^C-NMR (100 MHz, CDCl~3~): δ 178.5, 175.4, 173.9, 143.6, 139.4, 131.9, 130.1, 129.4, 129.1, 128.8, 128.7, 128.4, 126.5, 126.3, 122.8, 108.4, 67.7, 58.8, 51.7, 47.6, 38.2, 26.1; HRMS (ESI): *m*/*z* calcd for C~27~H~23~N~3~NaO~3~^+^ \[M + Na\]^+^ 460.1637, found 460.1647.

*3′-(tert-Butyl)-1-methyl-5′-phenyl-2′,3′,3a′,6a′-tetrahydro-4′H-spiro\[indoline-3,1′-pyrrolo\[3,4-c\]pyrrole\]-2,4′,6′(5′H)-trione* (**4x**). White solid; 58.1 mg; 72% yield; 72:28 dr; ^1^H-NMR (400 MHz, CDCl~3~): δ 7.50 (d, *J* = 7.7 Hz, 3H), 7.37--7.30 (m, 4H), 6.87 (d, *J* = 7.9 Hz, 2H), 4.38 (d, *J* = 7.9 Hz, 1H), 3.75 (t, *J* = 8.0 Hz, 1H), 3.58 (d, *J* = 8.1 Hz, 1H), 3.22 (s, 3H), 1.19 (s, 9H); ^13^C-NMR (100 MHz, CDCl~3~): δ 178.8, 176.3, 173.5, 143.6, 130.0, 129.3, 128.8, 126.5, 126.2, 122.8, 108.4, 68.4, 67.3, 52.2, 47.0, 33.2, 29.7, 26.2; HRMS (ESI): *m*/*z* calcd for C~24~H~25~N~3~NaO~3~^+^ \[M + Na\]^+^ 426.1794, found 426.1808.

*5-Methoxy-1-methyl-3′,5′-diphenyl-2′,3′,3a′,6a′-tetrahydro-4′H-spiro\[indoline-3,1′-pyrrolo\[3,4-c\]pyrrole\]-2,4′,6′(5′H)-trione* (**5a**). White solid; 74.3 mg; 82% yield; 83:17 dr; ^1^H-NMR (400 MHz, CDCl~3~): δ 7.54 (d, *J* = 7.5 Hz, 2H), 7.42 (dd, *J* = 14.5, 6.9 Hz, 3H), 7.39--7.32 (m, 3H), 7.23 (d, *J* = 7.8 Hz, 2H), 6.94 (s, 1H), 6.89 (d, *J* = 8.5 Hz, 1H), 6.78 (d, *J* = 8.4 Hz, 1H), 5.80 (d, *J* = 8.6 Hz, 1H), 3.99 (t, *J* = 8.3 Hz, 1H), 3.76 (s, 3H), 3.55 (d, *J* = 7.9 Hz, 1H), 3.21 (s, 3H); ^13^C-NMR (100 MHz, CDCl~3~): δ 178.6, 174.1, 173.4, 155.9, 138.0, 137.1, 129.1, 128.5, 128.3, 128.2, 127.3, 127.0, 126.2, 114.5, 114.3, 108.7, 68.2, 60.9, 55.8, 51.1, 49.6, 26.2; HRMS (ESI): *m*/*z* calcd for C~27~H~23~N~3~NaO~4~^+^ \[M + Na\]^+^ 476.1586, found 476.1605.

*5-Methoxy-1-methyl-3′-(4-nitrophenyl)-5′-phenyl-2′,3′,3a′,6a′-tetrahydro-4′H-spiro\[indoline-3,1′-pyrrolo\[3,4-c\]pyrrole\]-2,4′,6′(5′H)-trione* (**5b**). White solid; 79.7 mg; 80% yield; 82:18 dr; ^1^H-NMR (400 MHz, CDCl~3~): δ 8.26 (dd, *J* = 8.4, 4.9 Hz, 3H), 7.88 (d, *J* = 8.6 Hz, 2H), 7.48 (d, *J* = 7.7 Hz, 2H), 7.42 (d, *J* = 7.2 Hz, 1H), 6.91 (d, *J* = 8.4 Hz, 3H), 6.79 (d, *J* = 8.5 Hz, 1H), 5.63 (d, *J* = 6.8 Hz, 1H), 3.95 (t, *J* = 10.8 Hz, 1H), 3.86 (s, 3H), 3.57 (dd, *J* = 10.0, 7.0 Hz, 1H), 3.17 (s, 3H); ^13^C-NMR (100 MHz, CDCl~3~): δ 177.29 (s), 175.51 (s), 173.89 (s), 156.90 (s), 148.76 (s), 137.30 (s), 131.74 (s), 130.47 (s), 129.04 (d, *J* = 31.4 Hz), 128.76 (s), 127.66 (s), 126.87 (s), 126.41 (s), 123.94 (s), 114.48 (s), 111.45 (s), 109.36 (s), 69.20 (s), 61.17 (s), 55.97 (s), 53.48 (s), 52.95 (s), 26.26 (s). HRMS (ESI): *m*/*z* calcd for C~27~H~22~N~4~NaO~6~^+^ \[M + Na\]^+^ 521.1437, found 521.1437.

*5-Chloro-1-methyl-3′,5′-diphenyl-2′,3′,3a′,6a′-tetrahydro-4′H-spiro\[indoline-3,1′-pyrrolo\[3,4-c\]pyrrole\]-2,4′,6′(5′H)-trione* (**5c**). White solid; 77.7 mg; 85% yield; 75:25 dr; ^1^H-NMR (400 MHz, CDCl~3~): δ 7.53 (d, *J* = 7.2 Hz, 3H), 7.39-7.31 (m, 7H), 7.21 (d, *J* = 7.3 Hz, 3H), 5.76 (d, *J* = 8.8 Hz, 1H), 4.02 (t, *J* = 8.3 Hz, 1H), 3.53 (d, *J* = 7.9 Hz, 1H), 3.22 (s, 3H); ^13^C-NMR (100 MHz, CDCl~3~): δ 178.4, 174.0, 173.3, 142.3, 137.7, 130.1, 129.2, 128.8, 128.7, 128.6, 128.4, 128.3, 127.4, 127.3, 126.1, 109.4, 67.9, 60.9, 51.0, 49.4, 26.3; HRMS (ESI): *m*/*z* calcd for C2~6~H~20~ClN~3~NaO~3~^+^ \[M + Na\]^+^ 480.1091, found 480.1103.

*5-Chloro-1-methyl-3′-(4-nitrophenyl)-5′-phenyl-2′,3′,3a′,6a′-tetrahydro-4′H-spiro\[indoline-3,1′-pyrrolo\[3,4-c\]pyrrole\]-2,4′,6′(5′H)-trione* (**5d**). White solid; 82.3 mg; 82% yield; 78:22 dr; ^1^H-NMR (400 MHz, CDCl~3~): δ 8.22 (d, *J* = 7.9 Hz, 2H), 7.84 (d, *J* = 7.7 Hz, 2H), 7.52--7.43 (m, 4H), 7.41 (d, *J* = 6.3 Hz, 2H), 6.78 (t, *J* = 8.4 Hz, 2H), 5.56 (d, *J* = 6.1 Hz, 1H), 3.85 (d, *J* = 9.9 Hz, 1H), 3.54 (t, *J* = 9.8 Hz, 1H), 3.14 (s, 3H); ^13^C-NMR (100 MHz, CDCl~3~): δ 177.2, 175.5, 173.9, 148.5, 147.6, 142.5, 130.3, 130.2, 129.3, 129.0, 127.7, 127.2, 126.8, 126.7, 124.6, 124.0, 110.0, 68.8, 61.2, 53.4, 52.8, 26.3; HRMS (ESI): *m*/*z* calcd for C~26~H~19~ClN~4~NaO~5~^+^ \[M + Na\]^+^ 525.0942, found 525.0962.

*3′,5′-Diphenyl-2′,3′,3a′,6a′-tetrahydro-4′H-spiro\[indoline-3,1′-pyrrolo\[3,4-c\]pyrrole\]-2,4′,6′(5′H)-trione* (**5e**). White solid; 55.6 mg; 68% yield; 69:31 dr; ^1^H-NMR (400 MHz, DMSO-*d*~6~): δ 10.46 (s, 1H), 7.44 (d, *J* = 26.8 Hz, 6H), 7.24 (d, *J* = 36.5 Hz, 8H), 5.53 (s, 1H), 4.27 (s, 1H), 3.88 (s, 1H); ^13^C-NMR (100 MHz, DMSO-*d*~6~): δ 181.3, 174.9, 174.3, 142.8, 140.0, 129.6, 129.4, 128.2, 128.0, 127.7, 127.4,127.3, 121.5, 109.8, 68.1, 60.6, 51.8, 50.4; HRMS (ESI): *m*/*z* calcd for C~25~H~19~N~3~NaO~3~^+^ \[M + Na\]^+^ 432.1324, found 432.1341.

*1-Benzyl-3′,5′-diphenyl-2′,3′,3a′,6a′-tetrahydro-4′H-spiro\[indoline-3,1′-pyrrolo\[3,4-c\]pyrrole\]-2,4′,6′(5′H)-trione* (**5f**). White solid; 79.9 mg; 80% yield; 83:17 dr; ^1^H-NMR (400 MHz, DMSO-*d*~6~): δ 7.50 (s, 5H), 7.42--7.18 (m, 12H), 7.00 (s, 1H), 6.85 (s, 1H), 5.60 (s, 1H), 4.90 (s, 2H), 3.94 (s, 1H), 3.57 (s, 1H); ^13^C-NMR (100 MHz, DMSO-*d*~6~): δ 179.4, 174.8, 174.1, 143.2, 139.9, 136.7, 133.3, 129.7, 129.4, 129.1, 129.0, 128.8, 128.2, 128.0, 127.7, 127.4, 127.2, 122.3, 109.4, 68.0, 60.8, 52.1, 50.4, 42.9; HRMS (ESI): *m*/*z* calcd for C~32~H~25~N~3~NaO~3~^+^ \[M + Na\]^+^ 522.1794, found 522.1799.

*1-Benzyl-3′-(4-nitrophenyl)-5′-phenyl-2′,3′,3a′,6a′-tetrahydro-4′H-spiro\[indoline-3,1′-pyrrolo\[3,4-c\]pyrrole\]-2,4′,6′(5′H)-trione* (**5g**). White solid; 88.2 mg; 81% yield; 82:18 dr; ^1^H-NMR (400 MHz, DMSO-*d*~6~): δ 8.22 (d, *J* = 7.9 Hz, 2H), 7.85 (d, *J* = 7.9 Hz, 2H), 7.48 (d, *J* = 6.8 Hz, 2H), 7.41 (s, 3H), 7.37--7.32 (m, 2H), 7.30--7.21 (m, 5H), 7.04 (t, *J* = 6.8 Hz, 1H), 6.88 (d, *J* = 7.2 Hz, 1H), 5.05--4.85 (m, 2H), 4.70 (s, 1H), 4.13 (t, *J* = 7.7 Hz, 1H), 3.66 (d, *J* = 7.4 Hz, 1H); ^13^C-NMR (100 MHz, DMSO-*d*~6~): δ 179.3, 174.9, 174.0, 148.3, 147.2, 143.2, 136.6, 129.8, 129.5, 129.2, 129.1, 128.9, 127.9, 127.8, 127.4, 127.1, 127.0, 123.4, 122.5, 109.6, 68.0, 60.1, 52.2, 50.5, 43.0; HRMS (ESI): *m*/*z* calcd for C~32~H~24~N~4~NaO~5~^+^ \[M + Na\]^+^ 567.1644, found 567.1646.

*5′-(4-Chlorophenyl)-1-methyl-3′-phenyl-2′,3′,3a′,6a′-tetrahydro-4′H-spiro\[indoline-3,1′-pyrrolo\[3,4-c\]pyrrole\]-2,4′,6′(5′H)-trione* (**5h**). White solid; 60.3 mg; 66% yield; 67:33 dr; ^1^H-NMR (400 MHz, DMSO-*d*~6~): δ 7.55 (d, *J* = 7.9 Hz, 3H), 7.47 (d, *J* = 7.1 Hz, 3H), 7.28 (d, *J* = 7.1 Hz, 2H), 7.23 (d, *J* = 7.9 Hz, 3H), 7.01 (d, *J* = 8.2 Hz, 2H), 5.54 (d, *J* = 6.1 Hz, 1H), 3.90 (t, *J* = 8.1 Hz, 1H), 3.50 (d, *J* = 7.6 Hz, 1H), 3.14 (s, 3H); ^13^C-NMR (100 MHz, DMSO-*d*~6~): δ 179.1, 174.7, 174.0, 144.4, 139.9, 133.2, 131.6, 129.7, 129.5, 129.1, 128.2, 127.9, 127.7, 127.1, 127.0, 122.2, 108.7, 67.9, 60.7, 51.8, 50.5, 26.3; HRMS (ESI): *m*/*z* calcd for C~26~H~20~ClN~3~NaO~3~^+^ \[M + Na\]^+^ 480.1091, found 480.1110.

*5′-(4-Chlorophenyl)-1-methyl-3′-(4-nitrophenyl)-2′,3′,3a′,6a′-tetrahydro-4′H-spiro\[indoline-3,1′-pyrrolo\[3,4-c\]pyrrole\]-2,4′,6′(5′H)-trione* (**5i**). White solid; 81.3 mg; 81% yield; 82:18 dr; ^1^H-NMR (400 MHz, CDCl~3~): δ 8.22 (d, *J* = 8.6 Hz, 2H), 7.68 (d, *J* = 8.6 Hz, 2H), 7.42 (t, *J* = 3.3 Hz, 2H), 7.28 (dd, *J* = 14.0, 7.8 Hz, 2H), 7.15 (dd, *J* = 16.8, 8.2 Hz, 3H), 6.91 (d, *J* = 7.8 Hz, 1H), 5.91 (d, *J* = 8.5 Hz, 1H), 4.03 (t, *J* = 8.2 Hz, 1H), 3.59 (d, *J* = 8.0 Hz, 1H), 3.24 (s, 3H); ^13^C-NMR (100 MHz, CDCl~3~): δ 178.5, 173.6, 172.9, 147.7, 145.5, 143.7, 134.5, 130.6, 129.9, 129.5, 129.4, 128.1, 128.0, 127.2, 126.6, 125.0, 123.6, 123.0, 108.7, 68.0, 60.0, 50.8, 49.5, 26.3; HRMS (ESI): *m*/*z* calcd for C~26~H~19~ClN~4~NaO~5~^+^ \[M + Na\]^+^ 525.0942, found 525.0964.

*5′-(3-Chlorophenyl)-1-methyl-3′-(4-nitrophenyl)-2′,3′,3a′,6a′-tetrahydro-4′H-spiro\[indoline-3,1′-pyrrolo\[3,4-c\]pyrrole\]-2,4′,6′(5′H)-trione* (**5j**). White solid; 80.3 mg; 80% yield; 81:19 dr; ^1^H-NMR (400 MHz, CDCl~3~): δ 8.24 (d, *J* = 8.7 Hz, 2H), 7.71 (d, *J* = 8.7 Hz, 2H), 7.46--7.35 (m, 3H), 7.28 (dd, *J* = 12.9, 4.8 Hz, 2H), 7.21--7.11 (m, 2H), 6.93 (d, *J* = 7.8 Hz, 1H), 5.94 (d, *J* = 8.5 Hz, 1H), 4.06 (t, *J* = 8.2 Hz, 1H), 3.61 (d, *J* = 8.0 Hz, 1H), 3.26 (s, 3H); ^13^C-NMR (100 MHz, CDCl~3~): δ 178.4, 173.5, 172.7, 147.7, 145.4, 143.7, 134.8, 130.6, 130.3, 129.0, 128.0, 126.7, 126.3, 124.9, 124.2, 123.7, 123.1, 108.7, 68.0, 60.0, 50.7, 49.5, 26.3; HRMS (ESI): *m*/*z* calcd for C~26~H~19~ClN~4~NaO~5~^+^ \[M + Na\]^+^ 525.0942, found 525.0965.

*5′-(4-Methoxyphenyl)-1-methyl-3′-(4-nitrophenyl)-2′,3′,3a′,6a′-tetrahydro-4′H-spiro\[indoline-3,1′-pyrrolo\[3,4-c\]pyrrole\]-2,4′,6′(5′H)-trione* (**5k**). White solid; 79.7 mg; 80% yield; 78:22 dr; ^1^H-NMR (400 MHz, DMSO-*d*~6~): δ 8.29 (s, 2H), 7.87 (s, 2H), 7.10 (d, *J* = 34.9 Hz, 8H), 5.26 (s, 1H), 4.48 (s, 1H), 3.99 (s, 1H), 3.78 (s, 3H), 3.09 (s, 3H); ^13^C-NMR (100 MHz, DMSO-*d*~6~): δ 177.9, 177.1, 175.3, 159.5, 150.8, 147.3, 144.4, 130.1, 129.8, 128.7, 128.6, 128.3, 125.2, 124.6, 124.3,124.1, 123.4, 114.7, 109.3, 100.0, 69.0, 60.9, 55.9, 53.6, 26.3; HRMS (ESI): *m*/*z* calcd for C~27~H~22~N~4~NaO~6~^+^ \[M + Na\]^+^ 521.1437, found 521.1450.

*5′-(3-Methoxyphenyl)-1-methyl-3′-(4-nitrophenyl)-2′,3′,3a′,6a′-tetrahydro-4′H-spiro\[indoline-3,1′-pyrrolo\[3,4-c\]pyrrole\]-2,4′,6′(5′H)-trione* (**5l**). White solid; 84.7 mg; 85% yield; 84:16 dr; ^1^H-NMR (400 MHz, CDCl~3~): δ 8.21 (d, *J* = 8.6 Hz, 2H), 7.70 (d, *J* = 8.6 Hz, 2H), 7.36 (ddd, *J* = 20.8, 14.1, 7.5 Hz, 4H), 7.14 (t, *J* = 7.5 Hz, 1H), 6.91 (dd, *J* = 11.2, 4.7 Hz, 2H), 6.79 (d, *J* = 7.9 Hz, 1H), 5.90 (d, *J* = 8.5 Hz, 1H), 4.03 (t, *J* = 8.2 Hz, 1H), 3.77 (s, 3H), 3.58 (d, *J* = 7.9 Hz, 1H), 3.23 (s, 3H); ^13^C-NMR (100 MHz, CDCl~3~): δ 178.6, 173.8, 173.1, 147.7, 145.7, 143.7, 132.5, 130.5, 130.0, 129.9, 128.1, 126.8, 125.1, 123.6, 123.0, 118.3, 114.4, 112.2, 108.6, 68.0, 60.0, 55.4, 50.8, 49.5, 26.2; HRMS (ESI): *m*/*z* calcd for C~27~H~22~N~4~NaO~6~^+^ \[M + Na\]^+^ 521.1437, found 521.1461.

*1-Methyl-3′-(4-nitrophenyl)-5′-(p-tolyl)-2′,3′,3a′,6a′-tetrahydro-4′H-spiro\[indoline-3,1′-pyrrolo\[3,4-c\]pyrrole\]-2,4′,6′(5′H)-trione* (**5m**). White solid; 78.1 mg; 81% yield; 82:18 dr; ^1^H-NMR (400 MHz, CDCl~3~): δ 8.21 (d, *J* = 8.6 Hz, 2H), 7.69(d, *J* = 8.6 Hz, 2H), 7.40(t, *J* = 7.5 Hz, 1H), 7.30 (d, *J* = 7.3 Hz, 1H), 7.28--7.21 (m, 2H), 7.13 (t, *J* = 7.5 Hz, 1H), 7.08 (d, *J* = 8.2 Hz, 2H), 6.89 (d, *J* = 7.8 Hz, 1H), 5.90 (d, *J* = 8.5 Hz, 1H), 4.02 (t, *J* = 8.2 Hz, 1H), 3.57 (d, *J* = 7.9 Hz, 1H), 3.23 (s, 3H), 2.36 (s, 3H); ^13^C-NMR (100 MHz, CDCl~3~): δ 178.6, 173.9, 173.2, 147.7, 145.7, 143.7, 138.9, 130.4, 129.9, 128.9, 128.1, 126.8, 125.9, 125.1, 123.6, 123.0, 108.6, 68.0, 60.0, 50.7, 49.5, 26.2, 21.2; HRMS (ESI): *m*/*z* calcd for C~27~H~22~N~4~NaO~5~^+^ \[M + Na\]^+^ 505.1488, found 505.1510.

4. Conclusions {#sec4-molecules-23-00582}
==============

In summary, we have developed a simple and efficient strategy for diastereoselective construction of structurally diverse succinimide-fused spiro\[pyrrolidine-2,3′-oxindoles\] by a one-pot three-component 1,3-dipolar cycloaddition reaction ofazomethine ylides generated in situ from 3-amino oxindolesand aldehydes with maleimides. A series of succinimide-fused spiro\[pyrrolidine-2,3′-oxindole\] compounds have been obtained in good to high yields (up to 93%) with moderate to excellent diastereoselectivities (up to \>95:5). The relative stereochemistry of products has been assigned by X-ray diffraction analysis. Further biological applications of 3-aminooxindoles are currently underway.
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![Representative bioactive succinimide-fused spiro\[pyrrolidine-2,3′-oxindoles\].](molecules-23-00582-g001){#molecules-23-00582-f001}

![Strategies for the construction of succinimide-fused spiro\[pyrrolidine-2,3′-oxindoles\].](molecules-23-00582-sch001){#molecules-23-00582-sch001}

![The three-component reaction of 3-amino-1-methylindolin-2-one hydrochloride **1a**, benzaldehyde **2a,** and *N*-phenylmaleimide **3a**. Prolonging reaction time would benefit the reaction.](molecules-23-00582-sch002){#molecules-23-00582-sch002}

![A variety of aldehyde substrates **2** were investigated under optimized reaction conditions.](molecules-23-00582-sch003){#molecules-23-00582-sch003}

![Screening of a series of 3-amino oxindoles **1** and maleimides **3**.](molecules-23-00582-sch004){#molecules-23-00582-sch004}

![X-ray crystal structure of product **4k**. All H atoms have been omitted for clarity.](molecules-23-00582-g002){#molecules-23-00582-f002}

molecules-23-00582-t001_Table 1

###### 

Optimization of reaction conditions ^a^.

  Entry    Base           Solvent      T (°C)   Time (h)   Yield ^b^ (%)   dr ^c^
  -------- -------------- ------------ -------- ---------- --------------- --------
  1        NaHCO~3~       CHCl~3~      30       16         60              74:26
  2        K~2~CO~3~      CHCl~3~      30       16         62              73:27
  3        KF/Al~2~O~3~   CHCl~3~      30       16         58              71:29
  4        NaOH           CHCl~3~      30       16         trace           \-
  5        DIPEA          CHCl~3~      30       16         65              81:19
  6        TEA            CHCl~3~      30       16         68              83:17
  7        TEA            CHCl~3~      30       24         74              84:16
  8        TEA            CH~2~Cl~2~   30       24         60              88:12
  9        TEA            DCE          30       24         61              83:17
  10       TEA            THF          30       24         62              69:31
  11       TEA            dioxane      30       24         41              80:20
  12       TEA            Et~2~O       30       24         55              69:31
  13       TEA            CH~3~OH      30       24         57              84:16
  14       TEA            C~2~H~5~OH   30       24         74              78:22
  15       TEA            toluene      30       24         37              71:29
  16       TEA            CH~3~CN      30       24         42              85:15
  17       TEA            CH~2~Cl~2~   reflux   24         86              88:12
  18 ^d^   TEA            CH~2~Cl~2~   reflux   24         85              88:12

^a^ Unless otherwise noted, all reactions were carried out with **1a** (0.1 mmol), **2a** (0.1 mmol), **3a** (0.11 mmol), and base (0.1 mmol) in solvent (1.0 mL) at specified temperature for 16 or 24 h. DIPEA: diisopropylethylamine, TEA: triethylamine, DCE: 1,2-dichloroethane. ^b^ Isolated yield. ^c^ Determined by ^1^H-NMR spectroscopy of the crude mixture. ^d^ Reaction was carried out with two-fold scale.

molecules-23-00582-t002_Table 2

###### 

Scope of aldehyde **2** ^a^.

  Entry   2,R^2^               4        Yield ^b^ (%)   dr ^c^
  ------- -------------------- -------- --------------- --------
  1       **2a**,Ph            **4a**   85              88:12
  2       **2b**,4-F-Ph        **4b**   80              81:19
  3       **2c**,3-F-Ph        **4c**   70              62:38
  4       **2d**,2-F-Ph        **4d**   90              92:8
  5       **2e**,4-Cl-Ph       **4e**   79              81:19
  6       **2f**,3-Cl-Ph       **4f**   71              76:24
  7       **2g**,2-Cl-Ph       **4g**   83              81:19
  8       **2h**,3,4-diCl-Ph   **4h**   85              86:14
  9       **2i**,4-Br-Ph       **4i**   81              \>95:5
  10      **2j**,3-Br-Ph       **4j**   65              67:33
  11      **2k**,2-Br-Ph       **4k**   90              93:7
  12      **2l**,4-NO~2~-Ph    **4l**   85              \>95:5
  13      **2m**,3-NO~2~-Ph    **4m**   83              \>95:5
  14      **2n**,2-NO~2~-Ph    **4n**   86              94:6
  15      **2o**,4-Me-Ph       **4o**   78              82:18
  16      **2p**,3-Me-Ph       **4p**   71              75:25
  17      **2q**,2-Me-Ph       **4q**   80              77:23
  18      **2r**,4-OMe-Ph      **4r**   84              83:17
  19      **2s**,3-OMe-Ph      **4s**   76              80:20
  20      **2t**,2-naphthyl    **4t**   93              94:6
  21      **2u**,2-furyl       **4u**   70              94:6
  22      **2v**,2-thienyl     **4v**   79              93:7
  23      **2w**,Benzyl        **4w**   76              77:23
  24      **2x**,*^t^*Bu       **4x**   72              72:28

^a^ All reactions were carried out with **1a** (0.2mmol), **2** (0.2 mmol), **3a** (0.22 mmol), TEA (0.2 mmol) in CH~2~Cl~2~ (2.0 mL) at reflux for 24 h. ^b^ Isolated yield. ^c^ Determined by ^1^H-NMR analysis of the crude reaction mixture.

molecules-23-00582-t003_Table 3

###### 

Scope of 3-amino oxindoles **1** and maleimides **3** ^a^.

  Entry   1        2,R^2^              3        5        Yield ^b^ (%)   dr ^c^
  ------- -------- ------------------- -------- -------- --------------- --------
  1       **1b**   **2a**,Ph           **3a**   **5a**   82              83:17
  2       **1b**   **2l**,4-NO~2~-Ph   **3a**   **5b**   80              82:18
  3       **1c**   **2a**,Ph           **3a**   **5c**   85              75:25
  4       **1c**   **2l**,4-NO~2~-Ph   **3a**   **5d**   82              78:22
  5       **1d**   **2a**,Ph           **3a**   **5e**   68              69:31
  6       **1e**   **2a**,Ph           **3a**   **5f**   80              83:17
  7       **1e**   **2l**,4-NO~2~-Ph   **3a**   **5g**   81              82:18
  8       **1a**   **2a**,Ph           **3b**   **5h**   66              67:33
  9       **1a**   **2l**,4-NO~2~-Ph   **3b**   **5i**   81              82:18
  10      **1a**   **2l**,4-NO~2~-Ph   **3c**   **5j**   80              81:19
  11      **1a**   **2l**,4-NO~2~-Ph   **3d**   **5k**   80              78:22
  12      **1a**   **2l**,4-NO~2~-Ph   **3e**   **5l**   85              84:16
  13      **1a**   **2l**,4-NO~2~-Ph   **3f**   **5m**   81              82:18

^a^ All reactions were carried out with **1** (0.2mmol), **2** (0.2 mmol), **3** (0.22 mmol), TEA (0.2 mmol) in CH~2~Cl~2~ (2.0 mL) at reflux for 24 h. ^b^ Isolated yield. ^c^ Determined by ^1^H-NMRanalysis of the crude reaction mixture.
